Cancer

Items 941-950 of 1388

per page
Set Descending Direction
  1. Enniatin A
    CAS  2503-13-1
    AG-CN2-0477
    AG-CN2-0477-MC050.5 mg
    CHF 220.00
    Enniatin A
  2. Enniatin A1
    CAS  4530-21-6
    AG-CN2-0478
    AG-CN2-0478-M0011 mg
    CHF 290.00
    Enniatin A1
  3. Enniatin B
    CAS  917-13-5
    AG-CN2-0479
    AG-CN2-0479-M0011 mg
    CHF 170.00
    AG-CN2-0479-M0055 mg
    CHF 660.00
    Enniatin B
  4. Enniatin B1
    CAS  19914-20-6
    AG-CN2-0480
    AG-CN2-0480-M0011 mg
    CHF 210.00
    Enniatin B1
  5. Enoxacin
    CAS  74011-58-8
    AG-CR1-3539
    AG-CR1-3539-M05050 mg
    CHF 35.00
    AG-CR1-3539-M250250 mg
    CHF 105.00
    Enoxacin
  6. Everolimus
    CAS  159351-69-6
    CDX-E0074
    CDX-E0074-M100100 mg
    CHF 530.00
    CDX-E0074-M250250 mg
    CHF 1'017.00
    Everolimus
  7. Everolimus
    CAS  159351-69-6
    AG-CN2-0520
    AG-CN2-0520-M0011 mg
    CHF 40.00
    AG-CN2-0520-M0055 mg
    CHF 75.00
    AG-CN2-0520-M02525 mg
    CHF 195.00
    Everolimus
  8. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  9. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  10. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper

Items 941-950 of 1388

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.